Amgen (AMGN) PT Raised to $260 at BMO Capital
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Amgen (NASDAQ: AMGN) to $260.00 (from $253.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
